Genecept Assayâ„¢ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
Not Applicable
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- Genetic: Assay-guided treatment (AGT)Other: Treatment-as-usual (TAU)
- First Posted Date
- 2015-12-17
- Last Posted Date
- 2020-08-28
- Lead Sponsor
- Genomind, LLC
- Target Recruit Count
- 305
- Registration Number
- NCT02634177
- Locations
- 🇺🇸
Thomas Jefferson University Mood Disorder Program, Philadelphia, Pennsylvania, United States
🇺🇸Boston Clinical Trials, Boston, Massachusetts, United States
🇺🇸Artemis Institute for Clinical Research, San Diego, California, United States
An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay
Not Applicable
Completed
- Conditions
- Treatment Resistant DepressionGeneralized Anxiety Disorder
- Interventions
- Device: Genecept Assay
- First Posted Date
- 2012-01-10
- Last Posted Date
- 2016-06-08
- Lead Sponsor
- Genomind, LLC
- Target Recruit Count
- 685
- Registration Number
- NCT01507155
- Locations
- 🇺🇸
Genomind, LLC, Chalfont, Pennsylvania, United States
An Open Label Study of the Geneceptâ„¢ Assay in Treatment Resistant Depression
Not Applicable
Withdrawn
- Conditions
- Major Depressive Disorder
- Interventions
- Device: Genecept Assay
- First Posted Date
- 2011-09-22
- Last Posted Date
- 2015-03-23
- Lead Sponsor
- Genomind, LLC
- Registration Number
- NCT01438242
- Locations
- 🇺🇸
Genomind, LLC, Chalfont, Pennsylvania, United States
Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)
Not Applicable
Terminated
- Conditions
- Major Depressive Disorder
- Interventions
- Device: Genecept Assay
- First Posted Date
- 2011-08-31
- Last Posted Date
- 2021-09-13
- Lead Sponsor
- Genomind, LLC
- Target Recruit Count
- 29
- Registration Number
- NCT01426516
- Locations
- 🇺🇸
Centerstone, Nashville, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath